By a News Reporter-Staff News Editor at Pharma Business Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Mckesson Corp. (Form DEFA14A) was posted on June 26, 2014.
The SIC code for this company is 5122, Wholesale Drugs, Proprietaries and Druggist Sundries.
There were 20 documents filed with this form. The SEC file number is 0001193125-14-249941.
The contact information for this company is ONE POST ST, MCKESSON PLAZA, SAN FRANCISCO CA 94104, 4159838300.
Our editors provided additional information about Form DEFA14A: Additional proxy soliciting materials-definitive.
A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.
For additional information on this SEC filing see: http://www.sec.gov/Archives/edgar/data/927653/0001193125-14-249941-index.html.
Keywords for this news article include: SEC Filing, Mckesson Corp., Wholesale Drugs, Proprietaries and Druggist Sundries.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
